ARTICLE
6 November 2015

Analysis Of Crowd-Based Financing In European Life Sciences

D
Dentons

Contributor

Crowdfunding is a relatively new phenomenon, meaning that regulations can differ substantially from country to country.
European Union Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Crowdfunding is a relatively new phenomenon, meaning that regulations can differ substantially from country to country. In Europe, some governments have already adopted new rules. In his article for the BIOCOM study Analysis of Crowd-based Financing in European Life Sciences, Partner Robert Michels describes the country-specific legal regulations governing crowd-based financing in European Life Sciences.

Download the Article

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More